SCHEMBL31739855

SCHEMBL31739855

c1nn(C2COC2)c2c1CNCCC2

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30793500 0.86 ALOX15 (0.32) —
SCHEMBL31739495 0.85 HTR2C (0.33) —
SCHEMBL23852144 0.77 BTK (0.35) —
SCHEMBL29373411 0.77 HTR2A (0.36) —
SCHEMBL26058671 0.77 PDE9A (0.37) —
Hydrochloric Acid SCHEMBL22406921 0.75 PDE9A (0.37) —
SCHEMBL31126104 0.71 PLK1 (0.42) —
SCHEMBL23852990 0.71 S1PR1 (0.31) —
SCHEMBL23641905 0.68 HSD11B1 (0.31) —
SCHEMBL22474050 0.68 DRD2 (0.37) —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20250368649-A1 TETRAHYDROPYRIDOPYRIMIDINE PAN-KRAS INHIBITORS MIRATI THERAPEUTICS INC (US) 2025-12-04 — — US disclosed
Send feedback